AcrIIIA1 is a protein–RNA anti-CRISPR complex that targets core Cas and accessory nucleases
Nucleic Acids Research · 11.12.2024 · 52 (22) · 13490-13514
DOI: 10.1093/nar/gkae1006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 18.11.2024. Verfasst von Lucy Chou-Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, University of Illinois, 601 S. Goodwin Avenue, Urbana, IL 61801, USA. Hauptthemen laut MEDLINE: CRISPR-Associated Proteins, CRISPR-Cas Systems. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, Burroughs Wellcome Fund, NIH HHS.
Abstract (Originalsprache)
Clustered regularly-interspaced short palindromic repeats (CRISPRs) and CRISPR-associated (Cas) proteins protect bacteria and archaea from their viruses, and anti-CRISPRs (Acrs) are small virus-encoded proteins that inhibit CRISPR-Cas immunity. Over 80 families of Acrs have been described to date; however, only three of these subvert Type III CRISPR-Cas immunity. Type III systems employ a complex network of Cas and accessory nucleases to degrade viral nucleic acids. Here, we discover and characterize AcrIIIA1, the first Type III-A specific anti-CRISPR protein. We demonstrate that AcrIIIA1 binds to Csm2 within the Cas10-Csm effector complex and attenuates Cas10’s DNase activity and second messenger production. Additionally, AcrIIIA1 associates with fragmented t(m)RNAs (acrIIIA1-RNAs), and we show that they co-purify with the Cas10-Csm complex during phage infection. Although the precise role(s) of acrIIIA1-RNAs remain unclear, we found that they bind stably to RNase R, a host-encoded nuclease known to bolster immunity, and RNase R has the capacity to degrade them. Altogether, our results support a model in which AcrIIIA1 and its associated RNAs target both core Cas and accessory nucleases to provide robust protection against Type III CRISPR-Cas immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, University of Illinois, 601 S. Goodwin Avenue, Urbana, IL 61801, USA.
- Department of Biological Sciences, University of Alabama, 1325 Hackberry Lane, Tuscaloosa, AL 35401, USA.
ORCID-Profile: Asma Hatoum-Aslan
Förderung
- NIAID NIH HHS
- Burroughs Wellcome Fund
- NIH HHS
- U.S. National Science Foundation
- National Institutes of Health
Zitieren
APA
Chou-Zheng, L., Howell, O., Boyle, T. A., Hossain, M., Walker, F. C., Sheriff, E. K., Aslan, B., & Hatoum-Aslan, A. (2024). AcrIIIA1 is a protein–RNA anti-CRISPR complex that targets core Cas and accessory nucleases. Nucleic Acids Research, 52(22), 13490-13514. https://doi.org/10.1093/nar/gkae1006
Vancouver
Chou-Zheng L, Howell O, Boyle TA, Hossain M, Walker FC, Sheriff EK, et al. AcrIIIA1 is a protein–RNA anti-CRISPR complex that targets core Cas and accessory nucleases. Nucleic Acids Research. 2024;52(22):13490-13514. doi:10.1093/nar/gkae1006
BibTeX
@article{ChouZheng2024,
author = {Chou-Zheng, Lucy and Howell, Olivia and Boyle, Tori A and Hossain, Motaher and Walker, Forrest C and Sheriff, Emma K and Aslan, Barbaros and Hatoum-Aslan, Asma},
title = {AcrIIIA1 is a protein–RNA anti-CRISPR complex that targets core Cas and accessory nucleases},
journal = {Nucleic Acids Research},
year = {2024},
volume = {52},
number = {22},
pages = {13490--13514},
doi = {10.1093/nar/gkae1006}
}
EUVIMED